Evidence map›Paper›PMID 32143463›Full record

ArticleInternational journal of molecular sciences2020

A Novel Way of Preventing Postoperative Pancreatic Fistula by Directly Injecting Profibrogenic Materials into the Pancreatic Parenchyma.

Sang Chul Lee, Tae Ho Hong, Ok-Hee Kim, Suk Joon Cho, Kee-Hwan Kim, Jin Sook Song, Kyu-Seok Hwang, Jae-Kyung Jung, Ha-Eun Hong, Haeyeon Seo and 6 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. The using of sealants in pancreatic surgery: A Systematic Review.Annals of medicine and surgery (2012) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 1 country.

Sang Chul LeeDepartment of Surgery, Daejeon St. Mary's Hospital, College of Medicine, the Catholic University of Korea, Daejeon 34943, Korea.ORCID 0000-0002-8681-7059
Tae Ho HongCatholic Central Laboratory of Surgery, Institute of Biomedical Industry, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Ok-Hee KimCatholic Central Laboratory of Surgery, Institute of Biomedical Industry, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Suk Joon ChoCollege of Pharmacy, Chungbuk National University, Cheongju 28644, Korea.
Kee-Hwan KimCatholic Central Laboratory of Surgery, Institute of Biomedical Industry, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Jin Sook SongBio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Korea.
Kyu-Seok HwangBio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Korea.ORCID 0000-0003-4606-1354
Jae-Kyung JungCollege of Pharmacy, Chungbuk National University, Cheongju 28644, Korea.
Ha-Eun HongCatholic Central Laboratory of Surgery, Institute of Biomedical Industry, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Haeyeon SeoCatholic Central Laboratory of Surgery, Institute of Biomedical Industry, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Ho Joong ChoiDepartment of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.ORCID 0000-0002-0862-098X
Joseph AhnDepartment of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Tae Yoon LeeDepartment of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Eunyoung RimDeparpment of Medicinal Chemistry and Pharmacology, University of Science & Technology, Daejeon 34113, Korea.
Kwan-Young JungBio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Korea.
Say-June KimCatholic Central Laboratory of Surgery, Institute of Biomedical Industry, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.ORCID 0000-0001-5171-4837
The Catholic University of Korea Seoul St. Mary's Hospital · KRKorea Research Institute of Chemical Technology · KRChungbuk National University · KRKorea University of Science and Technology · KRThe Catholic University of Korea Daejeon St. Mary's Hospital · KRThe Catholic University of Korea Uijeongbu St. Mary's Hospital · KR

Funding

Korea Research Institute of Chemical Technology KN19-23National Research Foundation of Korea NRF-2015R1D1A1A02062336National Research Foundation of Korea NRF-2018R1C1B6002932
6 · The paper itself

Abstract

This paper aims to validate if intrapancreatic injection of penicillin G can enhance hardness and suture holding capacity (SHC) of the pancreas through prompting the fibrosis process. Soft pancreatic texture is constantly mentioned as one of the most contributory predictors of postoperative pancreatic fistula (POPF). Soft pancreas has poor SHC and higher incidence of parenchymal tearing, frequently leading to POPF. From a library of 114 antibiotic compounds, we identified that penicillin G substantially enhanced pancreatic hardness and SHC in experimental mice. Specifically, we injected penicillin G directly into the pancreas. On determined dates, we measured the pancreatic hardness and SHC, respectively, and performed molecular and histological examinations for estimation of the degree of fibrosis. The intrapancreatic injection of penicillin G activated human pancreatic stellate cells (HPSCs) to produce various fibrotic materials such as transforming growth factor-β1 (TGF-β1) and metalloproteinases-2. The pancreatic hardness and SHC were increased to the maximum at the second day after injection and then it gradually subsided demonstrating its reversibility. Pretreatment of mice with SB431542, an inhibitor of the TGF-β1 receptor, before injecting penicillin G intrapancreatically, significantly abrogated the increase of both pancreatic hardness and SHC caused by penicillin G. This suggested that penicillin G promotes pancreatic fibrosis through the TGF-β1 signaling pathway. Intrapancreatic injection of penicillin G promotes pancreatic hardness and SHC by enhancing pancreatic fibrosis. We thus think that penicillin G could be utilized to prevent and minimize POPF, after validating its actual effectiveness and safety by further studies.

Indexed as

AnimalsAnti-Bacterial AgentsBenzamidesDigestive System Surgical ProceduresDioxolesDisease Models, AnimalFibrosisHumansMaleMatrix Metalloproteinase 2MiceMice, Inbred BALB CPancreasPancreatic FistulaPancreatic Stellate CellsPenicillin G4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideAnti-Bacterial AgentsBenzamidesDioxolesMatrix Metalloproteinase 2MMP2 protein, humanPenicillin GReceptors, Transforming Growth Factor betaTGFB1 protein, humanTransforming Growth Factor beta1fibrosispancreas texturepancreatic stellate cellspenicillin Gpostoperative pancreatic fistula (POPF)transforming growth factor-β1

Identifiers

PMID32143463
PMCPMC7084673
OpenAlexW3009959546

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.